Advanced Solid Malignancies Completed Phase 1 Trials for Tovetumab (DB12609)

Also known as: Advanced Solid Malignancy

IndicationStatusPhase
DBCOND0034803 (Advanced Solid Malignancies)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01102400A Study of MEDI-575 in Patients With Advanced Solid MalignanciesTreatment